# CARFILZOMIB
> **ANDA210823** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-11-25
## Drug
- **FDA Application Number:** ANDA210823
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CARFILZOMIB
- **Generic name:** Carfilzomib
- **Active ingredients:** CARFILZOMIB
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** EUGIA PHARMA
- **First approval:** 2022-11-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210823)
---
*MORVS · CC0 1.0*